BioPharma Dive

5 FDA decisions to watch in the first quarter of 2026

By the end of March, the agency could approve multiple “national priority” voucher winners, as well as a gene therapy it ...
Becker's Hospital Review

5 updates on FDA’s expedited drug review activity

The FDA expedited drug review activity in December 2025 includes six fast-tracked therapies and the first National ...
Detroit Free Press

FDA-Authorized Expanded Access Programs Utilizing Jaguar Health’s Novel Crofelemer Powder for Oral Solution to Treat Two Pediatric Intestinal Failure Patients with ...

SAN FRANCISCO, CA / ACCESS Newswire / September 30, 2025 / Jaguar Health (NASDAQ:JAGX) today announced that Jaguar family company Napo Pharmaceuticals (Napo) is providing the company’s novel ...
STAT

FDA voucher program has become vehicle for political interference in drug review decisions, staffers say

Lizzy Lawrence leads STAT’s coverage of the Food and Drug Administration. She was previously a medical devices reporter. You can reach Lizzy on Signal at lizzylaw.53. WASHINGTON — A new program ...
Becker's Hospital Review

Lawmakers raise concerns over FDA drug voucher program

Lawmakers are pressing the FDA for answers about its Commissioner’s National Priority Voucher program, voicing concerns over potential corruption, safety risks and transparency issues. In a Nov. 20 ...
MM&M

FDA’s new national priority voucher program wants to speed up drug approvals while lowering drug costs

FDA commissioner Dr. Marty Makary is beginning to make moves toward his promise of speeding up drug approval pathways at the agency. But he’s aiming to do things a bit differently than in the past — ...